Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20151
20161
20171
20182
20192
20201
20212
20221
20232
20241
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Unknown status6
Active, not recruiting5
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Gynecologic Oncology Group3
AbbVie2
AstraZeneca2
Genmab2
Hoffmann-La Roche2
Sichuan Baili Pharmaceutical Co., Ltd.2
Advenchen Laboratories, LLC1
Affiliated Cancer Hospital & Institute of Guangzhou Medical University1
Eli Lilly and Company1
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms25
Ovarian Neoplasms14
Carcinoma, Ovarian Epithelial12
Peritoneal Neoplasms3
Endometrial Neoplasms2
Uterine Cervical Neoplasms2
Neoplasm Metastasis1
Neoplasms1
Recurrence1
Vomiting1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.